Patents Assigned to Sequana Therapeutics, Inc.
  • Patent number: 5776762
    Abstract: The gene responsible for the autosomal recessive mouse obesity mutation tub was identified by positional cloning. The homologous human gene is also provided. The genes are used to produce tubby protein; in screening for compositions that modulate the expression or function of the tubby protein; and in studying associated physiological pathways. The DNA is further used as a diagnostic for genetic predisposition to obesity, retinal degeneration or cochlear degeneration. The mutation responsible for the tub phenotype is a G to T transversion that abolishes a donor splice site in the 3' coding region and results in a larger transcript containing the unspliced intron. A second, prematurely truncated transcript arises from the introduction of a premature polyadenylation site in the unspliced intron.
    Type: Grant
    Filed: September 17, 1996
    Date of Patent: July 7, 1998
    Assignees: Sequana Therapeutics, Inc., The Jackson Laboratory
    Inventors: Michael North, Patsy Nishina, Konrad Noben-Trauth, Juergen Naggert
  • Patent number: 5686598
    Abstract: The gene responsible for the autosomal recessive retinal degenerative disease RP 14 is identified, TULP1. The genes are used to produce the encoded protein; in screening for compositions that modulate the expression or function of TULP1 protein; and in studying associated physiological pathways. The DNA is further used as a diagnostic for genetic predisposition to retinal degeneration.
    Type: Grant
    Filed: August 22, 1996
    Date of Patent: November 11, 1997
    Assignees: The Jackson Laboratory, Sequana Therapeutics, Inc.
    Inventors: Michael North, Patsy Nishina, Juergen Naggert